Active, Not Recruiting
Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma
NCT03224767
- Conditions
- BRAF V600E Mutation Present, Craniopharyngioma, Neoplasms, +5 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
- Mills-Peninsula Medical Center Burlingame, California, United States